The COVID-19 Health Care Workers (HEROES) Study is an international collaboration of more than 20 countries across five continents (America, Europe, Africa, Asia, and Oceania), established to study the short- and medium-term impact of the COVID-19 pandemic on the mental health and wellbeing of he
UnLEASH is an online cohort study of substance use among lesbian, bisexual and queer women in Australia.
E-cigarette use has increased rapidly worldwide since their introduction to markets in the mid-to-late 2000's, particularly among young people. There remains substantial global debate regarding the safety and efficacy of these devices, and how they should be regulated.
ADAPT stands for Australians’ Drug Use: Adapting to Pandemic Threats. The ADAPT study is exploring the short and long-term impact of the COVID-19 pandemic on the experiences of Australians who use illicit drugs.
The Quit Smoking Study is a Clinical Trial being conducted by the National Drug and Alcohol Research Centre (NDARC) at UNSW Sydney. The trial is looking at different types of nicotine replacement products to see which is the most effective at helping low-income smokers quit.
The world-first CESSATE Stop Smoking Study will compare two quitting aids (Desmoxan and Champix) to find out if both medications work equally as well as each other, or if one is more effective for stopping smoking. The benefits for participants include:
This project attempts to understand the global epidemiology of infectious disease among prisoners in all countries.
NDARC has been invited to undertake research in partnership with NSW Aboriginal drug and alcohol Residential Rehabilitation Services. This research is unique in being embedded into the routine delivery of their services.
Smoking is a leading cause of preventable disease and death.
